AI-generated summary
The authors studied whether photobiomodulation therapy with a 660 nm laser, given before surgery, could improve the survival of skin flaps in 63 male Wistar rats. The preemptive group receiving 1.1 J per point showed a lower percentage of necrotic tissue and more blood vessels than the control group, which the authors say supports the treatment. The study was conducted in rats, so the findings may not apply to humans.
- Participants
- 63
- Who or what was studied
- Male Wistar rats
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The study was conducted in rats and the abstract does not describe a human population or clinical outcomes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Total energy
- 1.1 J, 4 J, 11 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Laser, Photobiomodulation, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.